- May 22 Sat 2010 13:04
- May 21 Fri 2010 01:00
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Double-Take Software, Inc.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Double-Take Software, Inc. (“Double-Take” or the “Company”) (NASDAQ:DBTK) related to the Company’s agreement to be acquired by Vision Solutions, Inc. The proposed transaction is valued at approximately $242 million.
Under the terms of the definitive merger agreement entered into by the parties, Double-Take stockholders will receive $10.55 in cash for each share of Double-Take common stock they hold. The transaction is expected to be completed in the third quarter of 2010. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Double-Take’s board of directors.
If you own shares of Double-Take Software, Inc., if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at http://www.howardsmithlaw.com.
- May 19 Wed 2010 01:17
Robbins Umeda LLP Announces an Investigation of the Acquisition of Virtual Radiologic Corporation by Private Equity Firm Providence Equity Partners
SAN DIEGO--(BUSINESS WIRE)--Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Virtual Radiologic Corporation ("VRC") (NASDAQ: VRAD) in connection with their actions in causing VRC to enter into a definitive agreement to be acquired by Providence Equity Partners ("Providence"). If the transaction is completed, Providence will acquire all of the outstanding common stock of VRC for $17.25 per share in cash. The companies expect the transaction to close in the third quarter of 2010. Upon completion, VRC will become a private company, wholly owned by Providence.
VRC's co-founder and Chief Medical Officer, Dr. Eduard Michel, who owns 6.0% of the Company's outstanding common shares, and Generation Partners, which owns 25.3% of the Company's common shares, have executed voting agreements under which they have agreed to vote in favor of the transaction.
Robbins Umeda LLP's investigation concerns whether the Board of Directors of VRC undertook a fair process to obtain fair consideration for all shareholders of VRC.